[
 {
  "document": {
   "authors": "Thrishna",
   "contact_info": "thrishna@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "32339248.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "HP",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20190130.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "FIXME",
     "type": "PATTERN",
     "value": ".*",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "HGNC",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Custom_Disease",
     "type": "LIST",
     "value": null,
     "value_list": [
      "COVID-19"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Dose",
     "type": "LIST",
     "value": null,
     "value_list": [
      "600 mg twice daily"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Species",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Research"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Preprint"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Results"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "JAMA Netw Open. 2020 Apr 1;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857.",
       "ref": "32339248",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Research"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Preprint"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Results"
       ]
      }
     },
     {
      "set": {
       "Custom_Disease": [
        "COVID-19"
       ]
      }
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     },
     {
      "evidence": "Hypertension (25 of 55 [45.5%]), alcohol use disorder (14 of 51 \\\n[27.5%]), and diabetes (14 of 55 [25.5%]) were the most frequent \\\ncomorbidities"
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "hypertension"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "alcohol use disorder"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "diabetes mellitus"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Older age (mean [SD] age, 54.7 [13.7] years vs 47.4 [13.3] years) and \\\nmore heart disease (5 of 28 [17.9%] vs 0) were seen in the high-dose \\\ngroup"
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "heart disease"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Occurrence of myocarditis (defined as a creatine kinase-MB [CKMB] \\\nlevel more than twice the upper normal limit), which may be a final \\\ncomplication of severe sepsis or a lesion triggered by the virus \\\nitself, was seen in 2 of 26 (7.7%) patients (1 patient per group)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "myocarditis"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "myocarditis"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Sepsis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Creatine phosphokinase (CK) and CKMB levels were elevated in 13 of 33 \\\npatients (39.4%) and 10 of 26 patients (38.4%), respectively"
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Elevated serum creatine phosphokinase"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "CKM"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Only 1 patient developed severe rhabdomyolysis, and causality could be \\\nattributed to the virus or to CQ, which is already known to cause \\\nmyolysis (Table 2)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Rhabdomyolysis"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Two of 37 patients (2.7%) in the high-dosage group, both with \\\nconfirmed COVID-19, experienced ventricular tachycardia before death, \\\nwithout torsade de pointes."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Ventricular tachycardia"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Hemoglobin decrease was observed in 11 of 42 patients (26.2%). \\\nCreatinine increase was observed in 16 of 38 (42.1%)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Increased hemoglobin concentration"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "HP",
         "name": "Abnormal circulating creatinine level"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Despite the small sample size, in an exploratory multivariate \\\nanalysis, the high-dosage CQ was no longer associated with death when \\\ncontrolled by age (odds ratio, 2.8; 95% CI, 0.9-8.5)."
     },
     {
      "set": {
       "Dose": [
        "600 mg twice daily"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "chloroquine diphosphate"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Mortality"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Dose"
      ]
     },
     {
      "evidence": "In 5 patients with chronic cardiac disease, 3 (60.0%) died; their \\\nclinical details are presented in Table 3."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "FIXME",
         "name": "chronic cardiac disease"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_Disease"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     }
    ]
   }
  ]
 }
]